Analysis of BRCA1 gene rearrangements in breast carcinomas by RT-PCR and ER, PR, HER2NEU status by IHC and HPE correlation

Journal of Clinical and Diagnostic Research

Volumn 6, Issue 10, 2012, Pages 1663-1668

  Prakhya, Srivatsa ^a   Prakash, Geetha ^a  

^a Meenakhi Medical College   (India)

Author keywords

BRCA1 gene; Breast cancer; Immunohistochemistry; RT PCR

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BASE PAIRING; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER PATIENT; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE REARRANGEMENT; GENETIC SCREENING; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUTATIONAL ANALYSIS; OUTPATIENT DEPARTMENT; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURGICAL WARD; TEACHING HOSPITAL; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 84871877246     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2012/4587.2640     Document Type: Article

References (16)

1. Murthy NS, Chaudhry K, Nadayil D, Agarwal UK, Saxena S. The Changing Trends of Breast Cancer: the Indian Scenario. Indian Journal Of Cancer National Cancer Registry Programme (ICMR), Division of Non-Communicable Diseases, Indian Council of Medical Research. Indian Journal of Cancer. 2009;46:1 73-77.
2. Hellman, Samuel. Dogma and Inquisition in Medicine. Cancer. 1993;71(1): 2430-33.
3. Olson, James. 2002. Bathsheba's Breast: Women, Cancer, and History. Baltimore: John Hopkins Press.
4. Zafrani B, Aubriot MH, Mouret E, et al. The high sensitivity and the specificity of immunohistochemistry in the detection of the hormone receptors in breast carcinoma: comparison with the biochemical determination in a prospective study of 793 cases. Histopathology. 2000;37:536-45.
5. Taucher P, Rudas M, Mader RM, et al. Do we need HER-2/neu testing for all the patients with primary breast carcinomas? Cancer. 2003;98:2547-53.
6. Ellis IO, Schnitt SJ, Sastre-Garau X, et al. Invasive breast carcinoma. In: Tavassoli FA, Sevilee P, eds. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003;13-59. World Health Organization Classification of Tumours.
7. Press MF, Hung G, Godolphin W, et al. The sensitivity of the HER-2/ neu antibodies in archival tissue samples: a potential source of error in the immunohistochemical studies of the oncogene expression. Cancer Res. 1994;54:2771-77.
8. Miller K. The breast HER2 module. Immunocytochemistry. 2006;5: 66-70.
9. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC. The linkage of early-onset familial breast cancer to chromosome 17q21. Science. December. 1990; 250(4988): 1684-89.
10. Starita LM,. Parvin JD. The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair. Current Opinion in Cell Biology. 2003;15 (3): 345-50.
11. Paterson JW. BRCA1: a review of the structure and the putative functions. Dis. Markers. February, 1998; 13 (4): 261-74.
12. Mazoyer S. The genomic rearrangements in the BRCA1 and the BRCA2 genes. Hum Mutat. 2005; 25 (5): 415-22.
13. Casilli F. et al. The rapid detection of the novel BRCA1 rearrangements in high-risk breast-ovarian cancer families by doing multiplex PCR of the short fluorescent fragments. Hum Mutat. 2002; 20 (3): 218-26.
14. Barrois M. et al. A real-time PCR-based gene dosage assay for detecting the BRCA1 rearrangements in breast-ovarian cancer families. Clin Genet. 2004; 65 (2): 131-36.
15. Narod SA, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, Ponder BAJ et al An evaluation of the genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet. 1994; 56:254-64.
16. Johannsson OT, Idvall I, Anderson C, Borg A, Barkardottir RB, Egilsson V, Olsson H. The tumour biological features of BRCA1-induced breast and ovarian cancers. Eur J Cancer. 1997; 33(3):362-71.